N. Scott Fine - Aug 27, 2021 Form 4 Insider Report for Cyclo Therapeutics, Inc. (CYTH)

Role
Chief Executive Officer, Director
Signature
/s/ N. Scott Fine
Stock symbol
CYTH
Transactions as of
Aug 27, 2021
Transactions value $
$0
Form type
4
Date filed
8/30/2021, 07:02 PM
Next filing
Sep 15, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYTH Stock Option (Right to buy) Award $0 +57.3K $0.00 57.3K Aug 27, 2021 Common Stock 57.3K $7.46 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests over a four year period in equal monthly installments.